Cancer statistics, 2015

CA Cancer Journal for Clinicians

Volumn 65, Issue 1, 2015, Pages 5-29

  Siegel, Rebecca L ^a   Miller, Kimberly D ^a   Jemal, Ahmedin ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

cancer cases; cancer statistics; death rates; incidence; mortality; survival; trends

Indexed keywords

ARTICLE; BONE CANCER; BRAIN CANCER; BREAST CANCER; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SCREENING; CANCER STATISTICS; CANCER SURVIVAL; CAUSE OF DEATH; CHILDHOOD CANCER; DIGESTIVE SYSTEM CANCER; ENDOCRINE TUMOR; EYE CANCER; FEMALE GENITAL TRACT CANCER; GYNECOLOGIC CANCER; HUMAN; JOINT CANCER; LEUKEMIA; LUNG CANCER; LYMPHOMA; MALE GENITAL TRACT CANCER; MALIGNANT NEOPLASTIC DISEASE; MEDICAL SOCIETY; MOUTH CANCER; MYELOMA; PHARYNX CANCER; RACE DIFFERENCE; SEX DIFFERENCE; SKIN CANCER; SOCIAL STATUS; SOFT TISSUE CANCER; SURVIVAL TIME; TREND STUDY; UNITED STATES; URINARY TRACT CANCER; FEMALE; INCIDENCE; MALE; MORTALITY; NEOPLASMS; NON PROFIT ORGANIZATION; PUBLIC HEALTH SERVICE; REGISTER; SEX RATIO; SURVIVAL RATE;

AMERICAN CANCER SOCIETY; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASMS; REGISTRIES; SEER PROGRAM; SEX DISTRIBUTION; SURVIVAL RATE; UNITED STATES;

EID: 84920837701     PISSN: 00079235     EISSN: 15424863     Source Type: Journal    
DOI: 10.3322/caac.21254     Document Type: Article

References (65)

1. Surveillance, Epidemiology, and End Results (SEER) Program. SEER Stat Database: Mortality-All COD, Aggregated With State, Total US (1969-2011) . Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Cancer Statistics Branch; 2014; underlying mortality data provided by National Center for Health Statistics 2014.
2. Wingo PA, Cardinez CJ, Landis SH, et al. Long-term trends in cancer mortality in the United States, 1930-1998. Cancer. 2003; 97 (suppl 12): 3133-3275.
3. Murphy SL, Xu J, Kochanek KD,. Deaths: Final Data for 2010. National Vital Statistics Reports. Vol 64. No. 4. Hyattsville, MD: National Center for Health Statistics; 2013.
4. Surveillance, Epidemiology, and End Results (SEER) Program. SEER Stat Database: Incidence-SEER 9 Regs Research Data, Nov. 2013 Sub (1973-2011) -Linked To County Attributes-Total US, 1969-2012 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2014.
5. Surveillance, Epidemiology, and End Results (SEER) Program. SEER Stat Database: Incidence-SEER 13 Regs Research Data, Nov. 2013 Sub (1992-2011) -Linked To County Attributes-Total US, 1969-2012 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2014.
6. Surveillance, Epidemiology, and End Results (SEER) Program. SEER Stat Database: Incidence-SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases, Nov. 2013 Sub (2000-2011) -Linked To County Attributes-Total US, 1969-2012 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2014.
7. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2011. Bethesda, MD: National Cancer Institute; 2014.
8. Surveillance, Epidemiology, and End Results (SEER) Program. SEER Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence-CiNA Analytic File, 1995-2011, for Expanded Races, Custom File With County, ACS Facts and Figures Projection Project, North American Association of Central Cancer Registries. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2014.
9. Surveillance, Epidemiology, and End Results (SEER) Program. SEER Stat Database: North American Association of Central Cancer Registries (NAACCR) Incidence-CiNA Analytic File, 1995-2011, for NHIAv2 Origin, Custom File With County, ACS Facts and Figures Projection Project, North American Association of Central Cancer Registries. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2014.
10. Copeland G, Lake A, Firth R, et al. Cancer in North America: 2007-2011. Vol 1. Combined Cancer Incidence for the United States, Canada and North America. Springfield, IL: North American Association of Central Cancer Registries Inc; 2014.
11. Copeland G, Lake A, Firth R, et al. Cancer in North America: 2007-2011. Vol 2. Registry-Specific Cancer Incidence in the United States and Canada. Springfield, IL: North American Association of Central Cancer Registries Inc; 2014.
12. Fritz A, Percy C, Jack A, et al. International Classification of Diseases for Oncology. 3rd ed. Geneva: World Health Organization; 2000.
13. Statistical Research and Applications Branch. DevCan: Probability of Developing or Dying of Cancer Software. Version 6.7.1. Bethesda, MD: Statistical Research and Applications Branch, National Cancer Institute; 2005.
14. Surveillance Research Program, National Cancer Institute. SEER Stat Software. Version 8.1.5. Bethesda, MD: National Cancer Institute; 2014.
15. Joinpoint Regression Program, Version 4.1.1. Bethesda, MD: Statistical Research and Applications Branch, National Cancer Institute; 2014.
16. Clegg LX, Feuer EJ, Midthune DN, Fay MP, Hankey BF,. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst. 2002; 94: 1537-1545.
17. Surveillance, Epidemiology, and End Results (SEER) Program. SEER Stat Database: Incidence-SEER 13 Regs Research Data (with SEER Delay Factors), Nov. 2013 Sub (1992-2011) -Linked To County Attributes-Total US, 1969-2012 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2014.
18. Surveillance, Epidemiology, and End Results (SEER) Program. SEER Stat Database: Incidence-SEER 9 Regs Research Data (with SEER Delay Factors), Nov. 2013 Sub (1973-2011) -Linked To County Attributes-Total US, 1969-2012 Counties. Bethesda, MD: National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2014.
19. Pickle LW, Hao Y, Jemal A, et al. A new method of estimating United States and state-level cancer incidence counts for the current calendar year. CA Cancer J Clin. 2007; 57: 30-42.
20. Zhu L, Pickle LW, Ghosh K, et al. Predicting US- and state-level cancer counts for the current calendar year: Part II: evaluation of spatiotemporal projection methods for incidence. Cancer. 2012; 118: 1100-1109.
21. National Cancer Institute. Cancer Query System: Delay-Adjusted SEER Incidence Factors. surveillance.cancer.gov/delay/canques.html. Accessed October 6, 2014.
22. Chen HS, Portier K, Ghosh K, et al. Predicting US- and state-level cancer counts for the current calendar year: Part I: evaluation of temporal projection methods for mortality. Cancer. 2012; 118: 1091-1099.
23. Kabat GC, Anderson ML, Heo M, et al. Adult stature and risk of cancer at different anatomic sites in a cohort of postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2013; 22: 1353-1363.
24. Walter RB, Brasky TM, Buckley SA, Potter JD, White E,. Height as an explanatory factor for sex differences in human cancer. J Natl Cancer Inst. 2013; 105: 860-868.
25. Potosky AL, Kessler L, Gridley G, Brown CC, Horm JW,. Rise in prostatic cancer incidence associated with increased use of transurethral resection. J Natl Cancer Inst. 1990; 82: 1624-1628.
26. Potosky AL, Miller BA, Albertsen PC, Kramer BS,. The role of increasing detection in the rising incidence of prostate cancer. JAMA. 1995; 273: 548-552.
27. Holford TR, Cronin KA, Mariotto AB, Feuer EJ,. Changing patterns in breast cancer incidence trends. J Natl Cancer Inst Monogr. 2006;(36): 19-25.
28. Kim HJ, Fay MP, Feuer EJ, Midthune DN,. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19: 335-351.
29. Edwards BK, Ward E, Kohler BA, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010; 116: 544-573.
30. Cress RD, Morris C, Ellison GL, Goodman MT,. Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992-2001. Cancer. 2006; 107 (suppl 5): 1142-1152.
31. Siegel RL, Ward EM, Jemal A,. Trends in colorectal cancer incidence rates in the United States by tumor location and stage, 1992-2008. Cancer Epidemiol Biomarkers Prev. 2012; 21: 411-416.
32. Centers for Disease Control and Prevention, National Center for Health Statistics. National Health Interview Surveys, 2000, 2013. Public use data files, 2001, 2014.
33. Harris JE,. Cigarette smoking among successive birth cohorts of men and women in the United States during 1900-80. J Natl Cancer Inst. 1983; 71: 473-479.
34. Jemal A, Ma J, Rosenberg PS, Siegel R, Anderson WF,. Increasing lung cancer death rates among young women in southern and midwestern States. J Clin Oncol. 2012; 30: 2739-2744.
35. Legler JM, Feuer EJ, Potosky AL, Merrill RM, Kramer BS,. The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States. Cancer Causes Control. 1998; 9: 519-527.
36. Draisma G, Etzioni R, Tsodikov A, et al. Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context. J Natl Cancer Inst. 2009; 101: 374-383.
37. Howard DH, Tangka FK, Guy GP, Ekwueme DU, Lipscomb J,. Prostate cancer screening in men ages 75 and older fell by 8 percentage points after Task Force recommendation. Health Aff (Millwood). 2013; 32: 596-602.
38. Drazer MW, Prasad SM, Huo D, et al. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making. Cancer. 2014; 120: 1491-1498.
39. Li J, German R, King J, et al. Recent trends in prostate cancer testing and incidence among men under age of 50. Cancer Epidemiol. 2012; 36: 122-127.
40. Ferdinand R, Mitchell SA, Batson S, Tumur I,. Treatments for chronic myeloid leukemia: a qualitative systematic review. J Blood Med. 2012; 3: 51-76.
41. Pinsky PF, Church TR, Izmirlian G, Kramer BS,. The National Lung Screening Trial: results stratified by demographics, smoking history, and lung cancer histology. Cancer. 2013; 119: 3976-3983.
42. National Lung Screening Trial Research Team, Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011; 365: 395-409.
43. Welch HG, Schwartz LM, Woloshin S,. Are increasing 5-year survival rates evidence of success against cancer? JAMA. 2000; 283: 2975-2978.
44. Ezzati M, Friedman AB, Kulkarni SC, Murray CJ,. The reversal of fortunes: trends in county mortality and cross-county mortality disparities in the United States. PLoS Med. 2008; 5: e66.
45. Grauman DJ, Tarone RE, Devesa SS, Fraumeni JF Jr,. Alternate ranging methods for cancer mortality maps. J Natl Cancer Inst. 2000; 92: 534-543.
46. Bertuccio P, Chatenoud L, Levi F, et al. Recent patterns in gastric cancer: a global overview. Int J Cancer. 2009; 125: 666-673.
47. Anderson WF, Camargo MC, Fraumeni JF Jr, Correa P, Rosenberg PS, Rabkin CS,. Age-specific trends in incidence of noncardia gastric cancer in US adults. JAMA. 2010; 303: 1723-1728.
48. Camargo MC, Anderson WF, King JB, et al. Divergent trends for gastric cancer incidence by anatomical subsite in US adults. Gut. 2011; 60: 1644-1649.
49. Jemal A, Thun MJ, Ries LA, et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008; 100: 1672-1694.
50. Holford TR, Meza R, Warner KE, et al. Tobacco control and the reduction in smoking-related premature deaths in the United States, 1964-2012. JAMA. 2014; 311: 164-171.
51. US Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress. A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
52. Berry DA, Cronin KA, Plevritis SK, et al. Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005; 353: 1784-1792.
53. Etzioni R, Tsodikov A, Mariotto A, et al. Quantifying the role of PSA screening in the US prostate cancer mortality decline. Cancer Causes Control. 2008; 19: 175-181.
54. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004; 54: 78-93.
55. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB,. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002; 287: 2106-2113.
56. Gross CP, Smith BD, Wolf E, Andersen M,. Racial disparities in cancer therapy: did the gap narrow between 1992 and 2002? Cancer. 2008; 112: 900-908.
57. DeNavas-Walt C, Proctor BD, Smith JC,. US Census Bureau, Current Population Reports, P60-245. Income, Poverty, and Health Insurance Coverage in the United States: 2012. Washington, DC: US Government Printing Office; 2013.
58. Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M,. Trends in breast cancer by race and ethnicity. CA Cancer J Clin. 2003; 53: 342-355.
59. Menashe I, Anderson WF, Jatoi I, Rosenberg PS,. Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis. J Natl Cancer Inst. 2009; 101: 993-1000.
60. Press R, Carrasquillo O, Sciacca RR, Giardina EG,. Racial/ethnic disparities in time to follow-up after an abnormal mammogram. J Womens Health (Larchmt). 2008; 17: 923-930.
61. Tammemagi CM, Nerenz D, Neslund-Dudas C, Feldkamp C, Nathanson D,. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA. 2005; 294: 1765-1772.
62. Albain KS, Unger JM, Crowley JJ, Coltman CA Jr, Hershman DL,. Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. J Natl Cancer Inst. 2009; 101: 984-992.
63. Parkin DM,. The global health burden of infection-associated cancers in the year 2002. Int J Cancer. 2006; 118: 3030-3044.
64. White MC, Espey DK, Swan J, Wiggins CL, Eheman C, Kaur JS,. Disparities in cancer mortality and incidence among American Indians and Alaska Natives in the United States. Am J Public Health. 2014; 104 (suppl 3): S377-S387.
65. DeSantis C, Siegel R, Bandi P, Jemal A., Breast cancer statistics, 2011. CA Cancer J Clin. 2011; 61: 409-418.